Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China flag China · Delayed Price · Currency is CNY
11.71
+0.03 (0.26%)
May 8, 2026, 3:04 PM CST

SHE:000403 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,6002,6312,6542,3252,3961,966
Other Revenue
1.141.141.053.279.595.27
2,6012,6332,6552,3292,4051,972
Revenue Growth (YoY)
0.28%-0.83%14.00%-3.18%21.98%87.80%
Cost of Revenue
1,5721,5441,3521,1301,1511,064
Gross Profit
1,0281,0891,3031,1991,254907.93
Selling, General & Admin
444.44438.17437.26465.81565.05419
Research & Development
56.1355.9255.1879.6975.3635.63
Other Operating Expenses
26.5622.2622.0721.6916.815.28
Operating Expenses
539.77525.12509.9565.15666.86477.73
Operating Income
488.69563.97793.13633.7587.01430.2
Interest Expense
-19.59-18.19-10.67-9.63-12.03-10.78
Interest & Investment Income
59.3963.5278.0175.0868.2262.3
Currency Exchange Gain (Loss)
0.010.010.13-0.122.4-0.21
Other Non Operating Income (Expenses)
3.51-0.30.030.64-2.23-3.44
EBT Excluding Unusual Items
532.02609.01860.61699.67643.37478.06
Impairment of Goodwill
-78.6-78.6----103.18
Gain (Loss) on Sale of Investments
5.684.36.38-18.974.9374.21
Gain (Loss) on Sale of Assets
0.720.76-0.12-0.540.440.27
Asset Writedown
-17.86-17.86-3.46-1.29-3.59-0.49
Legal Settlements
------2.14
Other Unusual Items
-15.94-17.3-10.879.2515.2411.28
Pretax Income
426.02500.3852.78688.11660.39458.01
Income Tax Expense
72.6980.77107.7476.6472.766.47
Earnings From Continuing Operations
353.33419.54745.04611.47587.69391.54
Minority Interest in Earnings
-0.18-0.270.280.64-0.56-0.48
Net Income
353.15419.27745.32612.11587.13391.06
Net Income to Common
353.15419.27745.32612.11587.13391.06
Net Income Growth
-50.43%-43.75%21.76%4.25%50.14%110.29%
Shares Outstanding (Basic)
993953956947950917
Shares Outstanding (Diluted)
993953956947950919
Shares Change (YoY)
2.33%-0.28%0.88%-0.33%3.38%44.25%
EPS (Basic)
0.360.440.780.650.620.43
EPS (Diluted)
0.360.440.780.650.620.43
EPS Growth
-51.56%-43.59%20.71%4.60%45.23%45.78%
Free Cash Flow
-544.84-549.39-198.92301.74145.5882.06
Free Cash Flow Per Share
-0.55-0.58-0.210.320.150.09
Dividend Per Share
--0.3850.1540.0620.043
Dividend Growth
--150.06%149.27%43.16%-
Gross Margin
39.54%41.37%49.08%51.48%52.13%46.05%
Operating Margin
18.79%21.42%29.88%27.21%24.41%21.82%
Profit Margin
13.58%15.93%28.08%26.28%24.41%19.83%
Free Cash Flow Margin
-20.95%-20.87%-7.49%12.96%6.05%4.16%
EBITDA
622.69696.19918.23770.71704.63538.01
EBITDA Margin
23.94%26.45%34.59%33.10%29.30%27.29%
D&A For EBITDA
133.99132.22125.1137.02117.62107.82
EBIT
488.69563.97793.13633.7587.01430.2
EBIT Margin
18.79%21.42%29.88%27.21%24.41%21.82%
Effective Tax Rate
17.06%16.14%12.63%11.14%11.01%14.51%
Revenue as Reported
2,6012,6332,6552,3292,4051,972
Source: S&P Global Market Intelligence. Standard template. Financial Sources.